A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent Implantation in Non-diabetic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Antiplatelet Aggregation
Interventions
PROCEDURE

Blood Collection

4 weeks

Trial Locations (6)

55101

Local Institution, Mainz

75013

Local Institution, Paris

3435 CM

Local Institution, Nieuwegein

3015 GD

Local Institution, Rotterdam

G11 6NT

Local Institution, Glasgow

SO16 6YD

Local Institution, Southampton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT00493779 - A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent Implantation in Non-diabetic Patients | Biotech Hunter | Biotech Hunter